APPLICATION
ANDA091563
TYPE
ANDA
ORIGINAL APPROVAL
2012-12-31
LATEST ACTION
2021-11-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
DISULFIRAMPrescription
DISULFIRAM 500MG · TABLET · ORAL
DISULFIRAMPrescription
DISULFIRAM 250MG · TABLET · ORAL
Approval history
2021-11-02Manufacturing (CMC) · Supplement 7AP
2012-12-31OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.